首页|联合亚麻醉剂量艾司氯胺酮复合超声下椎旁阻滞应用于胸腔镜手术患者的临床价值

联合亚麻醉剂量艾司氯胺酮复合超声下椎旁阻滞应用于胸腔镜手术患者的临床价值

扫码查看
目的 探讨联合亚麻醉剂量艾司氯胺酮复合超声下椎旁阻滞应用于胸腔镜手术患者的临床价值.方法 选取2022 年12 月至2024 年3 月拟行胸腔镜手术患者308 例,按照随机数字表法分为艾司氯胺酮组和对照组各154 例.2 组均行全身麻醉,且艾司氯胺酮组予艾司氯胺酮0.1 mg/kg静脉注射复合超声下椎旁阻滞,对照组予等量0.9%氯化钠注射液静脉注射复合超声下椎旁阻滞.比较2 组术后6、12、24、48、72h静息与咳嗽时疼痛视觉模拟评分法(VAS)评分,麻醉前(T0)、给药后5 min(T1)、神经阻滞操作时(T2)、手术开始时(T3)、手术30 min时(T4)、术后即刻(T5)心率、平均动脉压(MAP),术前、术后24h、术后72h简易精神状态量表(MMSE)评分、术后镇痛药物使用情况、术后恢复情况及麻醉不良反应情况.结果 艾司氯胺酮组术后6、12、24、48、72h静息时、咳嗽时VAS评分均低于对照组(P<0.05);T2~T4 时艾司氯胺酮组心率、MAP较对照组低(P<0.05);艾司氯胺酮组术后 24、72 h MMSE评分高于对照组(P<0.05);艾司氯胺酮组术后72h舒芬太尼用量、曲马多使用次数少于对照组(P<0.01);艾司氯胺酮组术后麻醉恢复室停留时间、术后首次进食时间、下床活动时间均较对照组短(P<0.01);2 组麻醉不良反应总发生率比较差异无统计学意义(P>0.05).结论 全身麻醉联合亚麻醉剂量艾司氯胺酮复合超声下椎旁阻滞应用于胸腔镜手术可有效保障患者血流动力学稳定,缓解术后疼痛,减轻术后认知功能损伤,减少其他镇痛药使用,提高术后恢复质量,且安全可靠.
Clinical Value of Subanesthetic Dose of Esketamine Combined with Ultrasound-assisted Paraspinal Block in Patients Undergoing Thoracoscopic Surgery
Objective To explore the clinical value of subanesthetic dose of Esketamine combined with ultrasound-assisted paraspinal block in patients undergoing thoracoscopic surgery.Methods A total of 308 patients scheduled for thora-coscopic surgery from December 2022 to March 2024 were selected and randomly divided into the Esketamine group(n=154)and the control group(n=154),according to random number table method.Both groups underwent ultrasound-guided pa-raspinal block under general anesthesia.The Esketamine group received an intravenous injection of 0.1 mg/kg Esketamine combined with ultrasound-guided paraspinal block,while the control group received an intravenous injection of an equivalent amount of 0.9%sodium chloride solution combined with ultrasound-guided paraspinal block.The visual analogue scale(VAS)pain scores at rest and during cough were compared between the two groups at 6,12,24,48,and 72 h after surgery.The heart rate(HR)and mean arterial pressure(MAP)were measured before anesthesia(T0),at 5 min after administration(T1),during the nerve block procedure(T2),at the beginning of surgery(T3),at 30 min after surgery(T4),and immedi-ately after surgery(T5).The scores of the mini-mental state examination(MMSE)were measured before surgery,at 24 h and 72 h after surgery.The recovery status and adverse reactions to anesthesia were also compared between the two groups.Re-sults The VAS scores of the Esketamine group at rest and during cough at 6,12,24,48,and 72 h after surgery were lower than those of the control group(P<0.05),and at T2-T4,the HR and MAP in the Esketamine group were lower than those in the control group(P<0.05).The MMSE scores of the Esketamine group were higher than those of the control group at 24 and 72 h after surgery(P<0.05),and the use of Sufentanil and Tramadol in the Esketamine group was less than that in the control group at 72 h after surgery(P<0.05,P<0.01).The duration of stay in anesthesia recovery room after surgery,the first time of food intake and off-bed activity in the Esketamine group were shorter than those in the control group(P<0.01).There was no significant difference in the total incidence of adverse reactions related to anesthesia between the two groups(P>0.05).Conclusion The application of general anesthesia combined with subanesthetic dose of Esketamine combined with ultrasound-assisted paraspinal block in thoracoscopic surgery can effectively ensure the stability of the patient's hemody-namics,alleviate postoperative pain,reduce postoperative cognitive impairment,reduce the use of other analgesics,and im-prove the quality of postoperative recovery,which is safe and reliable.

EsketamineUltrasound-guided paravertebral blockThoracic surgery,video-assistedGeneral anesthe-siaCognitive functionPain,after surgeryMean arterial pressureDrug toxicity

左明明、杨静、路敏、孙婧婧、张琳

展开 >

061000 河北 沧州,沧州市人民医院麻醉科

艾司氯胺酮 超声下椎旁阻滞 胸外科手术,电视辅助 全身麻醉 认知功能 疼痛,手术后 平均动脉压 药物毒性

2025

临床误诊误治
解放军白求恩国际和平医院

临床误诊误治

影响因子:0.914
ISSN:1002-3429
年,卷(期):2025.38(2)